Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wils

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Oral Oncology|October 10, 2020
Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up studyIlkay Evren, Elisabeth R Brouns, Leon J Wils, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG studyD J Wagener, W J Hoogenraad, P Rougier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer GroupR C Coombes, P S Schein, C E Chilvers, et al.
Nederlands Tijdschrift Voor Tandheelkunde|February 19, 2021
[Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression]L J Wils, J B Poell, I Evren, et al.
Lancet (London, England)|November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerP Rougier, E Van Cutsem, E Bajetta, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 4, 2020
Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progressionLeon J Wils, Jos B Poell, Ilkay Evren, et al.
The Journal of Hospital Infection|November 9, 2021
Airborne SARS-CoV-2 in home and hospital environments investigated with a high-powered air samplerP de Man, M A Ortiz, P M Bluyssen, et al.
Annals of Surgery|January 1, 2000
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative groupJ H Klinkenbijl, J Jeekel, T Sahmoud, et al.
The Journal of Pathology|July 29, 2025
New insights into the genetic progression of cancer through longitudinal analysis of oral lesionsLeon J Wils, Jos B Poell, Arjen Brink, et al.
International Journal of Cancer|September 7, 2022
Oral cancer prediction by noninvasive genetic screeningJos B Poell, Leon J Wils, Arjen Brink, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Oral Oncology|October 10, 2020
Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up studyIlkay Evren, Elisabeth R Brouns, Leon J Wils, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG studyD J Wagener, W J Hoogenraad, P Rougier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer GroupR C Coombes, P S Schein, C E Chilvers, et al.
Nederlands Tijdschrift Voor Tandheelkunde|February 19, 2021
[Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression]L J Wils, J B Poell, I Evren, et al.
Lancet (London, England)|November 10, 1998
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerP Rougier, E Van Cutsem, E Bajetta, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 4, 2020
Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progressionLeon J Wils, Jos B Poell, Ilkay Evren, et al.
The Journal of Hospital Infection|November 9, 2021
Airborne SARS-CoV-2 in home and hospital environments investigated with a high-powered air samplerP de Man, M A Ortiz, P M Bluyssen, et al.
Annals of Surgery|January 1, 2000
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative groupJ H Klinkenbijl, J Jeekel, T Sahmoud, et al.
The Journal of Pathology|July 29, 2025
New insights into the genetic progression of cancer through longitudinal analysis of oral lesionsLeon J Wils, Jos B Poell, Arjen Brink, et al.
International Journal of Cancer|September 7, 2022
Oral cancer prediction by noninvasive genetic screeningJos B Poell, Leon J Wils, Arjen Brink, et al.
Pageof 12